Dane Fritzsche, PharmD, BCOP

home / authors / dane-fritzsche-pharmd-bcop

Articles

Microscopic view of kidney

Adverse Effects Impact Treatment Selection for VEGF-Targeted Oral TKIs in Metastatic RCC

Cindy Nguyen, PharmD;Dane Fritzsche, PharmD, BCOP;Jina Yun, PharmD
December 13th 2023

Axitinib, cabozantinib, and lenvatinib are first-line treatment options.

Read More

Oral Oncolytics Expand Armamentarium in HR+/HER– Early-Stage Breast Cancer in Adjuvant Setting

Oral Oncolytics Expand Armamentarium in HR+/HER– Early-Stage Breast Cancer in Adjuvant Setting

Michelle Nguyen, PharmD Candidate;Grace Baek, PharmD, BCOP;Arianne Duong, PharmD, BCOP;Dane Fritzsche, PharmD, BCOP
October 11th 2022

New agents can offer a more tailored approach to therapy selection.

Read More

Brown Bag Consult®: Melanoma

Brown Bag Consult®: Melanoma

Thuy Nguyen, PharmD;Grace Baek, PharmD, BCOP;Dane Fritzsche, PharmD, BCOP
December 31st 2021

Melanoma is responsible for 80% of skin cancer deaths.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD